CEA, CA-19-9 AND CA-125 IN ASCITES-FLUID FROM CANCER-PATIENTS

被引：0
|
作者：
BHARGAVA, A [1 ]
PETRELLI, N [1 ]
PIVER, S [1 ]
NEMOTO, T [1 ]
DOUGLASS, H [1 ]
TAKITA, H [1 ]
KAE, L [1 ]
BROWN, W [1 ]
FITZPATRICK, J [1 ]
机构：
[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,BUFFALO,NY 14263
来源：
CLINICAL CHEMISTRY | 1986年 / 32卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1122 / 1122
页数：1
相关论文
共 50 条
  • [1] DETECTION OF CA-125, CA-19-9 AND CEA IN NORMAL AND PATHOLOGICAL TISSUE OF THE ADNEXA BY IMMUNHISTOCHEMISTRY
    NEUNTEUFEL, W
    BREITENECKER, G
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 1988, 48 (05) : 334 - 337
  • [2] CA-19-9 AND CA-125 DETERMINATION BY IMMUNOLUMINOMETRIC ASSAY
    PLEBANI, M
    FAGGIAN, D
    MASIERO, M
    GIACOMINI, A
    BURLINA, A
    [J]. JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1990, 28 (12): : 919 - 921
  • [3] THE TUMOR-MARKERS CA-125, CA-19-9, CA-15-3 AND CEA IN OVARIAN-CANCER
    HOFFMANN, L
    MULLERHAGEN, S
    FRANZ, G
    KLAPDOR, R
    DIETEL, M
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1987, 242 (1-4) : 371 - 372
  • [4] CA-125 AND CA-19-9 IN NON-HODGKINS-LYMPHOMA
    BUHL, C
    FULLBRANDT, U
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1986, 111 (23) : 921 - 922
  • [5] CA-125 AND CA-19-9 IN PERITONEAL, CYST AND AMNIOTIC FLUIDS
    INAUDI, P
    PASQUI, L
    TORRE, GC
    SEVERI, FM
    CENTINI, G
    GIOFFRE, W
    DANERO, S
    DANTONA, N
    [J]. MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1988, 5 (04): : 233 - 238
  • [6] CLINICAL USE OF CA-125 AND CA-19-9 IN PATIENTS WITH OVARIAN-CARCINOMA
    NEGISHI, Y
    IKEHATA, N
    AZUMA, T
    OKABE, K
    KOBAYASHI, K
    NUTAHARA, Y
    NAKAMURA, F
    SATO, H
    AKIYA, K
    [J]. TUMOUR BIOLOGY, 1986, 7 (04): : 265 - 265
  • [7] LUMINESCENCE IMMUNOASSAYS OF THE TUMOR-MARKERS CA-125 AND CA-19-9
    REUM, L
    KLINGLER, W
    MARKOWITZ, G
    DRAHOVSKY, M
    PUCHINGER, B
    [J]. JOURNAL OF BIOLUMINESCENCE AND CHEMILUMINESCENCE, 1988, 2 (04): : 248 - 248
  • [8] CA-125 AND CA-19-9 IMMUNOLOCALIZATION IN NORMAL, HYPERPLASTIC, AND CARCINOMATOUS ENDOMETRIUM
    PODCZASKI, E
    KAMINSKI, PF
    ZAINO, R
    [J]. CANCER, 1993, 71 (08) : 2551 - 2556
  • [9] COMPARISON OF CARCINOEMBRYONIC ANTIGEN (CEA), CANCER ANTIGEN-125 (CA-125), AND CARBOHYDRATE ANTIGEN (CA-19-9) SERUM LEVELS IN PATIENTS WITH OVARIAN OR PANCREATIC-CANCER
    SCHENKEN, LL
    PUGH, RP
    TIPPETT, BK
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 149 - 149
  • [10] DIAGNOSTIC-SIGNIFICANCE OF THE TUMOR-MARKERS CA-125, CA-19-9, CA-15-3 AND CEA IN ENDOMETRIOSIS
    CIRKEL, U
    OCHS, H
    LATUSSEK, B
    SCHNEIDER, HPG
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 1991, 51 (08) : 626 - 631
12345